Project Apollon – CAMG334ADE03

Basic data

Acronym:
Apollon
Title:
CAMG334ADE03
Duration:
18/12/2019 to 18/12/2022
Abstract / short description:
Assessment of Prolonged Safety and Tolerability of Erenumab in migraine patients in a long-term open-label study.

Involved staff

Managers

University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine

Contact persons

Faculty of Medicine
University of Tübingen
University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine

Local organizational units

Department of Neurology with Focus on Neurodegenerative Disorders
University Department of Neurology
Hospitals and clinical institutes, Faculty of Medicine

Funders

Nürnberg, Bayern, Germany
Help

will be deleted permanently. This cannot be undone.